España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Tarsus Pharmaceuticals
TARS
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$27.02
-0.01
-0.06%
Last update: 10:13 AM
15 minutes delayed
Get Report
Comment
Tarsus Pharmaceuticals (TARS) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Tarsus Pharmaceuticals (NASDAQ:TARS) Stock
Tarsus Pharmaceuticals Stock (NASDAQ: TARS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, May 13, 2024
HC Wainwright & Co. Maintains Buy on Tarsus P...
Benzinga Newsdesk
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Friday, May 10, 2024
Barclays Maintains Overweight on Tarsus Pharm...
Benzinga Newsdesk
Thursday, May 09, 2024
Analyst Ratings For Tarsus Pharmaceuticals
Benzinga Insights
Oppenheimer Maintains Outperform on Tarsus Ph...
Benzinga Newsdesk
Top 5 Health Care Stocks That Could Sink Your Portfolio In Q2
Avi Kapoor
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Wednesday, May 08, 2024
Tarsus Pharmaceuticals shares are trading hig...
Benzinga Newsdesk
Tarsus Pharmaceuticals Q1 2024 GAAP EPS $(1.0...
Benzinga Newsdesk
Tuesday, April 23, 2024
Tarsus Strengthens Financial Position And Ref...
Benzinga Newsdesk
Friday, March 01, 2024
Tarsus Prices $100M Public Offering Of 2,812,...
Benzinga Newsdesk
Thursday, February 29, 2024
Tarsus Pharmaceuticals Reveals Proposed $100M...
Benzinga Newsdesk
A Glimpse Into The Expert Outlook On Tarsus Pharmaceuticals Through 4 Analysts
Benzinga Insights
Goldman Sachs Maintains Neutral on Tarsus Pha...
Benzinga Newsdesk
Wednesday, February 28, 2024
HC Wainwright & Co. Maintains Buy on Tarsus P...
Benzinga Newsdesk
Barclays Maintains Overweight on Tarsus Pharm...
Benzinga Newsdesk
ICU Medical To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Wednesday
Avi Kapoor
Oppenheimer Reiterates Outperform on Tarsus P...
Benzinga Newsdesk
Tuesday, February 27, 2024
Tarsus Pharmaceuticals shares are trading hig...
Benzinga Newsdesk
Tarsus Pharmaceuticals Q4 EPS $(1.31) Beats $...
Benzinga Newsdesk
Earnings Scheduled For February 27, 2024
Benzinga Insights
Monday, February 26, 2024
Tarsus Pharmaceuticals's Earnings: A Preview
Benzinga Insights
Thursday, February 22, 2024
Tarsus Announces Topline Results From Phase 2...
Benzinga Newsdesk
Monday, January 29, 2024
SoFi Technologies Posts Q4 Earnings, Joins Cardlytics, McGrath RentCorp And Other Big Stocks Moving Higher On Monday
Avi Kapoor
Monday, December 11, 2023
Tarsus Announces Topline Results From Ersa Ph...
Benzinga Newsdesk
Monday, November 20, 2023
Goldman Sachs Initiates Coverage On Tarsus Ph...
Benzinga Newsdesk
Friday, November 10, 2023
Why Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
Tarsus Pharmaceuticals shares are trading hig...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy Rating for Tarsus Pharmaceuticals: Here's What You Need To Know
Benzinga Insights
Big Stocks Moving Higher On Friday: Synaptics Reports Q1 Beat; Joins Lyft, Hologic, Blink Charging
Lisa Levin
HC Wainwright & Co. Maintains Buy on Tarsus P...
Benzinga Newsdesk
Thursday, November 09, 2023
Tarsus Pharmaceuticals Q3 EPS $(1.28) Vs $(0....
Benzinga Newsdesk
Recap: Tarsus Pharmaceuticals Q3 Earnings
Benzinga Insights
Earnings Scheduled For November 9, 2023
Benzinga Insights
Wednesday, November 08, 2023
Earnings Preview: Tarsus Pharmaceuticals
Benzinga Insights
Monday, September 11, 2023
Expert Ratings for Tarsus Pharmaceuticals
Benzinga Insights
Guggenheim Maintains Buy on Tarsus Pharmaceut...
Benzinga Newsdesk
Thursday, August 24, 2023
Tarsus Pharmaceuticals, Inc. Announces That XDEMVY 0.25% Is Now Available At Pharmacies Nationwide For Prescription. The U.S. FDA Approved Drug On July 24, 2023, For The Treatment Of Demodex Blepharitis
Happy Mohamed
Monday, August 14, 2023
What 6 Analyst Ratings Have To Say About Tarsus Pharmaceuticals
Benzinga Insights
Guggenheim Reiterates Buy on Tarsus Pharmaceu...
Benzinga Newsdesk
Friday, August 11, 2023
HC Wainwright & Co. Maintains Buy on Tarsus P...
Benzinga Newsdesk
Thursday, August 10, 2023
Tarsus Pharmaceuticals Q2 EPS $(1.17) Down Fr...
Benzinga Newsdesk
Wednesday, August 02, 2023
Tarsus Pharmaceuticals Announces Pricing Of $...
Benzinga Newsdesk
Tuesday, August 01, 2023
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Late Monday, Tarsus Pharmaceuticals Announced...
Benzinga Newsdesk
Monday, July 31, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Wednesday, July 26, 2023
HC Wainwright & Co. Maintains Buy Rating for Tarsus Pharmaceuticals: Here's What You Need To Know
Benzinga Insights
HC Wainwright & Co. Maintains Buy on Tarsus P...
Benzinga Newsdesk
Tuesday, July 25, 2023
Tarsus Pharma Shares Under Pressure: Analyst Says Concerns Over Adverse Event Profile Overblown
Vandana Singh
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch